These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11356586)

  • 21. Subtype progression and pathophysiologic deterioration in early schizophrenia.
    McGlashan TH; Fenton WS
    Schizophr Bull; 1993; 19(1):71-84. PubMed ID: 8451614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.
    Ahmed AO; Strauss GP; Buchanan RW; Kirkpatrick B; Carpenter WT
    Schizophr Bull; 2015 Jul; 41(4):879-91. PubMed ID: 25399026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders.
    Fenton WS; McGlashan TH; Victor BJ; Blyler CR
    Am J Psychiatry; 1997 Feb; 154(2):199-204. PubMed ID: 9016268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroimaging evidence for the deficit subtype of schizophrenia.
    Voineskos AN; Foussias G; Lerch J; Felsky D; Remington G; Rajji TK; Lobaugh N; Pollock BG; Mulsant BH
    JAMA Psychiatry; 2013 May; 70(5):472-80. PubMed ID: 23467781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.
    Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L
    J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.
    Kirkpatrick B; Amador XF; Yale SA; Bustillo JR; Buchanan RW; Tohen M
    Schizophr Res; 1996 May; 20(1-2):79-90. PubMed ID: 8794496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia.
    Kopelowicz A; Zarate R; Tripodis K; Gonzalez V; Mintz J
    Am J Psychiatry; 2000 Jun; 157(6):987-93. PubMed ID: 10831481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attentional impairments in deficit and nondeficit forms of schizophrenia.
    Buchanan RW; Strauss ME; Breier A; Kirkpatrick B; Carpenter WT
    Am J Psychiatry; 1997 Mar; 154(3):363-70. PubMed ID: 9054784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reexamination of the characteristics of the deficit schizophrenia patients.
    Tiryaki A; Yazici MK; Anil AE; Kabakçi E; Karaağaoğlu E; Göğüş A
    Eur Arch Psychiatry Clin Neurosci; 2003 Oct; 253(5):221-7. PubMed ID: 14504990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Components of the smooth pursuit function in deficit and nondeficit schizophrenia.
    Hong LE; Avila MT; Adami H; Elliot A; Thaker GK
    Schizophr Res; 2003 Sep; 63(1-2):39-48. PubMed ID: 12892856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired insight in patients with newly diagnosed nonaffective psychotic disorders with and without deficit features.
    Trotman HD; Kirkpatrick B; Compton MT
    Schizophr Res; 2011 Mar; 126(1-3):252-6. PubMed ID: 20817414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case identification and stability of the deficit syndrome of schizophrenia.
    Kirkpatrick B; Buchanan RW; Breier A; Carpenter WT
    Psychiatry Res; 1993 Apr; 47(1):47-56. PubMed ID: 8516416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia.
    Kopelowicz A; Liberman RP; Mintz J; Zarate R
    Am J Psychiatry; 1997 Mar; 154(3):424-5. PubMed ID: 9054795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia.
    Ribeyre JM; Lesieur P; Varoquaux O; Dollfus S; Pays M; Petit M
    Biol Psychiatry; 1994 Aug; 36(4):230-6. PubMed ID: 7986887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics.
    Sota TL; Heinrichs RW
    Compr Psychiatry; 2004; 45(5):415-21. PubMed ID: 15332206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative symptoms and the course of positive symptoms in deficit schizophrenia.
    Gerbaldo H; Cassady S; Helisch A
    Psychopathology; 1995; 28(3):121-6. PubMed ID: 7675996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orbitofrontal cortex abnormality and deficit schizophrenia.
    Kanahara N; Sekine Y; Haraguchi T; Uchida Y; Hashimoto K; Shimizu E; Iyo M
    Schizophr Res; 2013 Feb; 143(2-3):246-52. PubMed ID: 23228712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history.
    Lysaker PH; Salyers MP
    Acta Psychiatr Scand; 2007 Oct; 116(4):290-8. PubMed ID: 17803759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.